1887

Abstract

SUMMARY

Clinical details are presented of 16 patients from whom thymine-requiring (thy) mutants of pathogenic organisms were isolated; all had been treated with co-trimoxazole. The urine of six patients infected with thy mutants contained levels of a thymine-like compound sufficient to support their growth. This might be the result either of the breakdown of pus cells or of thymine production by living bacteria that persist in stones or scar tissue, a suggestion supported by the observation of mutant growth “in satellitism” Since 1975 we have isolated mutants from patients who have had short courses of co-trimoxazole, in contrast to those we reported upon previously, all except one of whom had had long courses. We are now isolating thy mutants more frequently than hitherto. Secondary mutations to a low thymine requirement may now be occurring more rapidly, thereby allowing more mutant organisms to survive. The clinical significance of infection with thy mutants is not yet clear, but evidence is accumulating that they are pathogenic. Alternative chemotherapy is suggested for patients from whom such mutants have been isolated.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-11-1-33
1978-02-01
2022-01-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/11/1/medmicro-11-1-33.html?itemId=/content/journal/jmm/10.1099/00222615-11-1-33&mimeType=html&fmt=ahah

References

  1. Andrew M. H. E. 1973; Use of trimethoprim to obtain thymine-requiring mutants of Streptococcus faecalis. J. gen. Microbiol 74:195
    [Google Scholar]
  2. Arlinger L. 1971; Isotachophoresis in capillary tubes. Protides biol. Fluids 19:513
    [Google Scholar]
  3. Bailey R. R., Roberts A. R., Gower P. E., de Wardener H. E. 1971; Prevention of urinary-tract infection with low-dose nitrofurantoin. Lancet 2:1112
    [Google Scholar]
  4. Barker J., Healing D., Hutchison J. G. P. 1972; Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients. J. clin. Path 25:1086
    [Google Scholar]
  5. Barner H. D., Cohen S. S. 1959; Virus-induced acquisition of metabolic function. IV. Thymidilate synthetase in thymine-requiring Escherichia coli infected by T2 and T5 bacteriophages. J. biol. Chem 234:2987
    [Google Scholar]
  6. Cattell W. R., Chamberlain D. A., Fry I. K., McSherry M. A., Broughton C., O’Grady F. 1971; Long-term control of bacteriuria with trimethoprim-sulphonamide. Br. med. J 1:377
    [Google Scholar]
  7. Cleaver J. E. 1967; Thymidine metabolism and cell kinetics. Frontiers of biology series edited by Neuberger A., Tatum E. L. vol 6: Amsterdam: p 60
    [Google Scholar]
  8. Clowes R. C., Hayes W. 1968 Experiments in microbial genetics Oxford:
    [Google Scholar]
  9. Cowan S. T., Steel K. J. 1966 Manual for the identification of medical bacteria London:
    [Google Scholar]
  10. Everaerts F. M., Becker J. L. 1976 Isotachophoresis: theory, instrumentation and applications Amsterdam:
    [Google Scholar]
  11. Hayek L. J., Netherway J. 1976; Thymine-requiring bacteria. Lancet 1:1080
    [Google Scholar]
  12. Hoffee P. A., Robertson B. C. 1969; 2-Deoxyribose gene-enzyme complex in Salmonella typhimurium: regulation of phospho-deoxyribomutase. J. Bact 97:1386
    [Google Scholar]
  13. Jaffe J. J., McCormack J. J., Meymarian E. 1972; Comparative properties of schistosomal and filarial dihydrofolate reductases. Biochem. Pharmac 21:719
    [Google Scholar]
  14. Lacey R. W., Lewis E. L. 1973; Is co-trimoxazole bactericidal in sputum?. Br. med. J 4:165
    [Google Scholar]
  15. Lowbury E. J. L., Kidson A., Lilly H. A. 1964; A new selective blood agar medium for Streptococcus pyogenes and other haemolytic streptococci. J. clin. Path 17:231
    [Google Scholar]
  16. Mackey J. P., Sandys G. H. 1966; Diagnosis of urinary infections; clinical aspects. Br. med. J 1:1173
    [Google Scholar]
  17. Maskell R., Okubadejo O. A., Payne R. H. 1976; Thymine-requiring bacteria associated with co-trimoxazole therapy. Lancet 1:834
    [Google Scholar]
  18. Okubadejo O. A., Maskell R. M. 1973; Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo. J. gen. Microbiol 77:533
    [Google Scholar]
  19. Sandys G. H. 1960; A new method of preventing swarming of Proteus spp. with a description of a new medium suitable for use in routine laboratory practice. J. med. Lab. Technol 17:224
    [Google Scholar]
  20. Smellie J. M., Gruneberg R. N., Leakey A., Atkin W. S. 1976; Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infections: clinical aspects. Br. med. J 2:203
    [Google Scholar]
  21. Stacey K. A., Simson E. 1965; Improved method for the isolation of thymine-requiring mutants of Escherichia coli. J. Bact 90:554
    [Google Scholar]
  22. Tanner E. I., Bullin C. H. 1974; Thymidine-dependent Escherichia coli infection and some associated laboratory problems. J. clin. Path 27:565
    [Google Scholar]
  23. Tapsall J. W., Wilson E., Harper J. 1974; Thymine dependent strains of Escherichia coli selected by trimethoprim-sulphamethoxazole therapy. Pathology 6:161
    [Google Scholar]
  24. Then R., Angehrn P. 1974; Co-trimoxazole resistance. Br. med. J 1:78
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-11-1-33
Loading
/content/journal/jmm/10.1099/00222615-11-1-33
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error